Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chinol

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Cancer Research|August 17, 2000
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridgingM Guttinger, F Guidi, M Chinol, et al.
European Journal of Nuclear Medicine|February 5, 1999
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patientsM Cremonesi, M Ferrari, M Chinol, et al.
European Journal of Nuclear Medicine|June 17, 1999
Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patientsE Lazzeri, M Manca, N Molea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1988
Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibodyD J Hnatowich, M Chinol, D A Siebecker, et al.
British Journal of Cancer|August 28, 2003
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogueB Chini, M Chinol, P Cassoni, et al.
British Journal of Cancer|March 1, 2002
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot studyC Grana, M Chinol, C Robertson, et al.
Cancer Investigation|January 1, 1993
Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptakeR Gennuso, M K Spigelman, M Chinol, et al.
Melanoma Research|February 8, 2000
Sentinel node localization in primary melanoma: learning curve and resultsA Testori, M Bartolomei, C Grana, et al.
Biopolymers|March 27, 2003
90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignanciesG Paganelli, L Bodei, D Handkiewicz Junak, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Cancer Research|August 17, 2000
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridgingM Guttinger, F Guidi, M Chinol, et al.
European Journal of Nuclear Medicine|February 5, 1999
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patientsM Cremonesi, M Ferrari, M Chinol, et al.
European Journal of Nuclear Medicine|June 17, 1999
Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patientsE Lazzeri, M Manca, N Molea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1988
Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibodyD J Hnatowich, M Chinol, D A Siebecker, et al.
British Journal of Cancer|August 28, 2003
Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogueB Chini, M Chinol, P Cassoni, et al.
British Journal of Cancer|March 1, 2002
Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot studyC Grana, M Chinol, C Robertson, et al.
Cancer Investigation|January 1, 1993
Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptakeR Gennuso, M K Spigelman, M Chinol, et al.
Melanoma Research|February 8, 2000
Sentinel node localization in primary melanoma: learning curve and resultsA Testori, M Bartolomei, C Grana, et al.
Biopolymers|March 27, 2003
90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignanciesG Paganelli, L Bodei, D Handkiewicz Junak, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 27, 2001
Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients: phase I study and preliminary therapeutic resultsG Paganelli, M Bartolomei, M Ferrari, et al.
Pageof 5